Sign Up to like & get recommendations! 0
Published in 2017 at "Anales de pediatria"
DOI: 10.1016/j.anpedi.2017.07.001
Abstract: Moreira et al. manifiestan en su carta que no hay evidencia que sustente la recomendación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP) sobre la vacunación infantil antineumocócica en España con… read more here.
Sign Up to like & get recommendations! 2
Published in 2021 at "MethodsX"
DOI: 10.1016/j.mex.2021.101357
Abstract: Pneumonia is the leading cause of morbidity and mortality in children worldwide. The ten valent pneumococcal vaccine (PCV10) was introduced in Pakistan's Expanded Program on Immunization (EPI) in 2012 as a 3 + 0 schedule… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-214888
Abstract: A judicious analysis and comparison of studies on the immunogenicity of pneumococcal vaccine in patients with systemic lupus erythematosus (SLE)1–9 is hampered by wide heterogeneity in several factors, including differences in the immunoassays performed, cut-off… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.3663
Abstract: Background Immunisation with pneumococcal vaccine is the key prophylactic measure to protect patients with systemic lupus erythematosus (SLE) against severe respiratory infections. Objectives To study the efficacy and immunogenicity of 23-valent polysaccharide pneumococcal vaccine in… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "BMJ Open Respiratory Research"
DOI: 10.1136/bmjresp-2018-000393
Abstract: Introduction To evaluate WHO chest radiograph interpretation processes during a pneumococcal vaccine effectiveness study of children aged 3–35 months with suspected pneumonia in Sylhet, Bangladesh. Methods Eight physicians masked to all data were standardised to… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "American Journal of Health-System Pharmacy"
DOI: 10.2146/ajhp160916
Abstract: Streptococcus pneumoniae (pneumococcus) infection remains a major cause of morbidity and mortality among both the pediatric and geriatric populations in the United States.[1][1] According to the most recent Active Bacterial Core surveillance report from the… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.01754
Abstract: Vaccine effectiveness is mainly determined by the mechanism mediating protection, emphasizing the importance of unraveling the protective mechanism for novel pneumococcal vaccine development. We previously demonstrated that the regulatory T cell (Treg) immune response has… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.673392
Abstract: In every year, up to one million children die due to pneumococcal disease. Children infected with Human Immunodeficiency Virus (HIV) are mostly affected, as they appear to have higher rates of pneumococcal carriage and invasive… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Vaccines"
DOI: 10.3390/vaccines7040151
Abstract: Streptococcus pneumoniae remains a major public health hazard. Although Pneumococcal Conjugate Vaccines (PCVs) are available and have significantly reduced the rate of invasive pneumococcal diseases, there is still a need for new vaccines with unlimited… read more here.